2018
DOI: 10.37358/rc.18.8.6451
|View full text |Cite
|
Sign up to set email alerts
|

A Design of Experiment Approach to the Synthesis of Alendronate-incorporated Hydroxyapatite

Abstract: A design of experiment (DoE) approach is presented for the optimization of Alendronate-hydroxyapatite nanoparticles� synthesis. The synthesis was performed using the chemical precipitation technique from calcium nitrate, diammonium hydrogen phosphate and alendronate. Synthesis temperature, reactant addition rate and ripening time were chosen as the most relevant experimental factors for our synthesis. Design of Experiments was used in order to measure these conclusive process parameters and their effect on con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…Molecular weight and viscosity were chosen as responses. This method is readily applied in many fields for similar applications. , …”
Section: Methodsmentioning
confidence: 99%
“…Molecular weight and viscosity were chosen as responses. This method is readily applied in many fields for similar applications. , …”
Section: Methodsmentioning
confidence: 99%
“…A composite with a high incorporation efficiency of the drug was subsequently obtained. Furthermore, the hydroxyapatite appeared as a single crystalline phase [24].…”
Section: Synthesis and Characterization Of The Synthesized Hydroxyapamentioning
confidence: 99%
“…Four variables, namely gentamycin concentration, PLGA concentration, buffer concentration and stirring rate were evaluated in relation to nanoparticle size and encapsulation efficiency. A Full Factory (2 levels) interaction model experimental design was implemented using quality by design (QbD) approach, which is widely promoted by the Food and Drug Administration and the International Conference on Harmonization (ICH) [22,23]. Furthermore, a degradation study was conducted to evaluate the PLGA 65:35 used for the synthesis of gentamicin loaded nanoparticles.…”
Section: Introductionmentioning
confidence: 99%